• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用聚集诱导猝灭探针对完整的聚己内酯纳米粒子进行生物成像:通过口服给药的尺寸依赖性转位。

Bioimaging of Intact Polycaprolactone Nanoparticles Using Aggregation-Caused Quenching Probes: Size-Dependent Translocation via Oral Delivery.

机构信息

Key Laboratory of Smart Drug Delivery of MOE and PLA, School of Pharmacy, Fudan University, Shanghai, 201203, China.

Key Laboratory for Special Functional Materials of the Ministry of Education, Henan University, Kaifeng, 475001, China.

出版信息

Adv Healthc Mater. 2018 Nov;7(22):e1800711. doi: 10.1002/adhm.201800711. Epub 2018 Oct 21.

DOI:10.1002/adhm.201800711
PMID:30345713
Abstract

The limited information on biological fate impedes the development of more efficient polymeric nanoparticles for oral delivery of bio-macromolecules. In this study, the in vivo fate as well as the trans-epithelia transport of polycaprolactone (PCL) nanoparticles is explored by labeling with aggregation-caused quenching probes, which is capable of identifying intact nanoparticles. Live imaging and confocal laser scan microscopy confirm size-dependent absorption of PCL nanoparticles. In general, reducing particle size favors a faster and more oral absorption. Nanoparticles larger than 200 nm, such as 600 and 2000 nm, cannot be efficiently transported across the intestinal membrane. The absorbed nanoparticles (50 and 200 nm) mainly accumulate in the liver. Lymph may be the main absorption route for PCL nanoparticles, transporting 2.39 ± 1.81% and 0.98 ± 0.58% of administered 50 and 200 nm nanoparticles, respectively. Cellular uptake and transportation of PCL nanoparticles are also size dependent. Both enterocytes and M cells mediated transcytosis are involved in the transport of 50 nm PCL nanoparticles, while the M cell pathway is dominative for other nanoparticles. In conclusion, the study provides a valuable tool for bioimaging of intact polymeric nanoparticles as well as solid evidence supporting size-dependent translocation of the nanoparticles via oral delivery.

摘要

体内生物命运及聚己内酯(PCL)纳米粒的跨上皮转运研究

有限的生物命运信息阻碍了更高效的聚合物纳米粒用于生物大分子的口服给药。在这项研究中,通过使用聚集诱导猝灭探针进行标记,探索了聚己内酯(PCL)纳米粒的体内命运以及跨上皮转运,这种方法能够识别完整的纳米粒。活体成像和共聚焦激光扫描显微镜证实了 PCL 纳米粒的尺寸依赖性吸收。一般来说,减小颗粒尺寸有利于更快、更口服吸收。大于 200nm 的纳米粒,如 600nm 和 2000nm,不能有效地穿过肠膜运输。吸收的纳米粒(50nm 和 200nm)主要积聚在肝脏中。淋巴可能是 PCL 纳米粒的主要吸收途径,分别输送 50nm 和 200nm 纳米粒给药量的 2.39±1.81%和 0.98±0.58%。PCL 纳米粒的细胞摄取和转运也与尺寸有关。肠细胞和 M 细胞介导的转胞吞都参与了 50nm PCL 纳米粒的转运,而其他纳米粒的转运途径则以 M 细胞途径为主。总之,该研究为完整聚合物纳米粒的生物成像提供了有价值的工具,并为口服给药时纳米粒的尺寸依赖性转位提供了确凿的证据。

相似文献

1
Bioimaging of Intact Polycaprolactone Nanoparticles Using Aggregation-Caused Quenching Probes: Size-Dependent Translocation via Oral Delivery.使用聚集诱导猝灭探针对完整的聚己内酯纳米粒子进行生物成像:通过口服给药的尺寸依赖性转位。
Adv Healthc Mater. 2018 Nov;7(22):e1800711. doi: 10.1002/adhm.201800711. Epub 2018 Oct 21.
2
Size-Dependent Translocation of Nanoemulsions via Oral Delivery.尺寸依赖型纳米乳液经口服递药。
ACS Appl Mater Interfaces. 2017 Jul 5;9(26):21660-21672. doi: 10.1021/acsami.7b04916. Epub 2017 Jun 23.
3
Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel.聚酯-固体脂质混合纳米粒改善了在胃肠道中的稳定性,促进了拉罗他赛的口服递送。
Mol Pharm. 2017 Nov 6;14(11):3750-3761. doi: 10.1021/acs.molpharmaceut.7b00503. Epub 2017 Oct 4.
4
The Trigeminal Pathway Dominates the Nose-to-Brain Transportation of Intact Polymeric Nanoparticles: Evidence from Aggregation-Caused Quenching Probes.三叉神经通路主导完整聚合物纳米颗粒的鼻脑转运:来自聚集猝灭探针的证据。
J Biomed Nanotechnol. 2019 Apr 1;15(4):686-702. doi: 10.1166/jbn.2019.2724.
5
Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.载顺铂的 PCL 纳米粒的制备及经鼻腔给药的评价。
Drug Deliv. 2016 Sep;23(7):2144-2153. doi: 10.3109/10717544.2014.948643. Epub 2014 Dec 29.
6
Self-discriminating fluorescent hybrid nanocrystals: efficient and accurate tracking of translocation via oral delivery.自分辨荧光杂化纳米晶:通过口服给药实现高效准确的转位追踪。
Nanoscale. 2017 Dec 21;10(1):436-450. doi: 10.1039/c7nr06052a.
7
Cellular uptake and transcytosis of lipid-based nanoparticles across the intestinal barrier: Relevance for oral drug delivery.基于脂质的纳米颗粒跨肠道屏障的细胞摄取和转胞吞作用:对口服药物递送的意义。
J Colloid Interface Sci. 2016 Feb 1;463:258-65. doi: 10.1016/j.jcis.2015.10.057. Epub 2015 Oct 24.
8
Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration.冰片对不同粒径的聚乳酸-羟基乙酸共聚物纳米粒包封的9-硝基喜树碱经口服给药后的药代动力学的影响。
Drug Deliv. 2016 Nov;23(9):3417-3423. doi: 10.1080/10717544.2016.1189466. Epub 2016 Jun 1.
9
Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.聚乙二醇构象和粒径对纳米颗粒被HepG2细胞摄取效率的影响。
J Control Release. 2007 Mar 12;118(1):7-17. doi: 10.1016/j.jconrel.2006.11.028. Epub 2006 Dec 6.
10
The biological fate of orally administered mPEG-PDLLA polymeric micelles.口服 mPEG-PDLLA 聚合物胶束的生物命运。
J Control Release. 2020 Nov 10;327:725-736. doi: 10.1016/j.jconrel.2020.09.024. Epub 2020 Sep 15.

引用本文的文献

1
"Therapies Through Gut:" Targeted Drug Delivery for Non-Gastrointestinal Diseases by Oral Administration.“通过肠道进行治疗”:口服给药用于非胃肠道疾病的靶向药物递送
Adv Healthc Mater. 2025 Jul;14(17):e2403162. doi: 10.1002/adhm.202403162. Epub 2025 Mar 3.
2
Aggregation-Caused Quenching Dyes as Potent Tools to Track the Integrity of Antitumor Nanocarriers: A Mini-Review.聚集诱导猝灭染料作为追踪抗肿瘤纳米载体完整性的有力工具:综述。
Pharmaceuticals (Basel). 2025 Jan 27;18(2):176. doi: 10.3390/ph18020176.
3
Enteral Route Nanomedicine for Cancer Therapy.
肠内途径的癌症治疗纳米医学。
Int J Nanomedicine. 2024 Sep 25;19:9889-9919. doi: 10.2147/IJN.S482329. eCollection 2024.
4
Quantification of Microsphere Drug Release by Fluorescence Imaging with the FRET System.基于荧光共振能量转移(FRET)系统的荧光成像法定量微球药物释放
Pharmaceutics. 2024 Jul 31;16(8):1019. doi: 10.3390/pharmaceutics16081019.
5
2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin.2-单酰甘油模拟脂质体促进肠道淋巴转运提高二氢青蒿素口服生物利用度
Int J Nanomedicine. 2024 Jun 6;19:5273-5295. doi: 10.2147/IJN.S462374. eCollection 2024.
6
Current research trends of nanomedicines.纳米药物的当前研究趋势。
Acta Pharm Sin B. 2023 Nov;13(11):4391-4416. doi: 10.1016/j.apsb.2023.05.018. Epub 2023 May 20.
7
The feasibility of oral targeted drug delivery: Gut immune to particulates?口服靶向给药的可行性:肠道对微粒免疫吗?
Acta Pharm Sin B. 2023 Jun;13(6):2544-2558. doi: 10.1016/j.apsb.2022.10.020. Epub 2022 Oct 29.
8
Ionic co-aggregates (ICAs) based oral drug delivery: Solubilization and permeability improvement.基于离子共聚物(ICAs)的口服药物递送:增溶与通透性改善
Acta Pharm Sin B. 2022 Oct;12(10):3972-3985. doi: 10.1016/j.apsb.2022.04.011. Epub 2022 Apr 26.
9
Morin encapsulated chitosan nanoparticles (MCNPs) ameliorate arsenic induced liver damage through improvement of the antioxidant system and prevention of apoptosis and inflammation in mice.桑色素包裹的壳聚糖纳米粒(MCNPs)通过改善抗氧化系统以及预防小鼠细胞凋亡和炎症来减轻砷诱导的肝损伤。
Nanoscale Adv. 2022 May 17;4(13):2857-2872. doi: 10.1039/d2na00167e. eCollection 2022 Jun 28.
10
Investigation of the "Nose-to-Brain" Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability.鼻腔内 HupA 纳米乳剂“鼻脑”途径的研究及体内药代动力学和脑靶向能力评价。
Int J Nanomedicine. 2022 Aug 4;17:3443-3456. doi: 10.2147/IJN.S369978. eCollection 2022.